ENCHANTED试验:急性缺血性卒中功能结局质量的民族差异及其他决定因素
ENCHANTED试验纳入4016例溶栓急性缺血性卒中患者,分析90天健康相关生活质量(HRQoL)的预测因素并推导效用加权mRS。发现高龄、非亚洲裔、卒中严重度高、糖尿病、病前残疾、大动脉粥样硬化及代理评估者独立预测HRQoL差;亚洲人HRQoL较好但主要由中国人驱动。
要点
- 非亚洲裔是HRQoL差的独立预测因素(OR 1.91),但主要由中国人HRQoL较好驱动。
- 高龄、卒中严重度高、糖尿病、病前残疾和大动脉粥样硬化均独立预测HRQoL差。
- 效用加权mRS显示mRS 5至3之间改善带来的效用增益最大。
核心结论
- 溶栓急性缺血性卒中后,高龄、非亚洲裔、初始严重度高、糖尿病、病前残疾、大动脉粥样硬化及代理评估者与HRQoL差独立相关。
研究设计与样本
- ENCHANTED为国际准析因临床试验,比较不同剂量阿替普酶和血压控制强度,随机化后90天评估5维欧洲生活质量量表和mRS。
- 共4016例具有完整5维欧洲生活质量量表和mRS数据的急性缺血性卒中患者纳入分析。
主要发现
- HRQoL差的独立预测因素包括:每增加10岁(OR 1.19,95%CI 1.12-1.27)、非亚洲裔(OR 1.91,95%CI 1.61-2.27)、NIHSS每增加1分(OR 1.11,95%CI 1.09-1.12)、糖尿病(OR 1.41,95%CI 1.18-1.69)、病前mRS 1 vs 0(OR 1.62,95%CI 1.33-1.97)、大动脉粥样硬化性病因(OR 1.32,95%CI 1.12-1.54)及代理评估者(OR 2.35,95%CI 2.01-2.74)。
- 敏感性分析表明民族对HRQoL的影响由中国人(占亚洲人的62.9%)HRQoL较好所驱动。
- mRS 0至5对应的效用值分别为0.977、0.885、0.748、0.576、0.194和-0.174。
- 亚洲人中mRS与5维欧洲生活质量量表评分的相关性更强。
关键数值与推荐
- HRQoL差定义为5维欧洲生活质量量表效用评分≤均值。
- mRS 0至5的效用加权值依次为0.977、0.885、0.748、0.576、0.194、-0.174。
临床怎么用
- 对高龄、非亚洲裔、卒中严重度高、糖尿病、病前残疾、大动脉粥样硬化及代理评估的患者应关注HRQoL。
- 避免重大残疾(mRS 5至3的改善)对患者效用增益最大,治疗应着力于此。
局限性
- 亚洲人HRQoL较好的广泛意义受中国人占分析主导地位所限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Patient-centered outcomes are important. We aimed to determine predictors of health-related quality of life (HRQoL) and develop utility-weighted modified Rankin Scale (mRS) scores in thrombolyzed acute ischemic stroke patients from both arms of ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Methods- ENCHANTED was an international quasi-factorial clinical trial of different doses of intravenous alteplase and intensities of blood pressure control in acute ischemic stroke patients, with outcomes on the 5-Dimensional European Quality of Life Scale and mRS assessed at 90 days post-randomization. Logistic regression models were used to identify baseline predictors of poor HRQoL (≤mean 5-Dimensional European Quality of Life Scale utility scores). Ordinary least squares regression derived utility-weighted mRS scores. Results- In 4016 acute ischemic stroke patients with complete 5-Dimensional European Quality of Life Scale and mRS data, independent predictors of poor HRQoL were older age (odds ratio, 1.19 [95% CI, 1.12-1.27], per 10-year increase), non-Asian ethnicity (1.91 [1.61-2.27]), greater stroke severity on the National Institutes of Health Stroke Scale (1.11 [1.09-1.12]), diabetes mellitus (1.41 [1.18-1.69]), premorbid disability (mRS score 1 versus 0; 1.62 [1.33-1.97]), large vessel atheromatous pathogenesis (1.32 [1.12-1.54]), and proxy respondent (2.35 [2.01-2.74]). Sensitivity analyses indicate the ethnicity influence on HRQoL was driven by the high proportion of Chinese (62.9% of Asian) participants with better HRQoL compared with non-Chinese or other Asian groups. Derived utility values across mRS scores 0 to 5 were 0.977, 0.885, 0.748, 0.576, 0.194, and -0.174, respectively. Correlations between mRS and 5-Dimensional European Quality of Life Scale scores were stronger in Asians. Conclusions- HRQoL is worse after thrombolyzed acute ischemic stroke in the elderly, non-Asians, with greater initial severity, diabetes mellitus, premorbid disability, due to large vessel atheroma, and proxy assessment. The broader significance of better HRQoL in Asians is tempered by Chinese participants dominating analyses. From utility-weighted mRS scores indicating the greatest steps in mRS scores are between 5 and 3, treatments to avoid major disability provide the greatest benefits for patients. Registration- URL: https://www.clinicaltrials.gov. Unique identifier: NCT01422616.
引用
- Chen X, Wang X, Delcourt C, et al. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial. Stroke. 2019. PMID: 31822251. doi:10.1161/STROKEAHA.119.027639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。